Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.16 million shares were traded. SPRO stock price reached its highest trading level at $1.14 during the session, while it also had its lowest trading level at $1.1.
Ratios:
For a deeper understanding of Spero Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.68 and its Current Ratio is at 2.68. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on September 23, 2022, Upgraded its rating to Outperform and sets its target price to $8 from $2 previously.
H.C. Wainwright reiterated its Buy rating for the stock on January 22, 2021, while the target price for the stock was revised from $33 to $40.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 07 ’24 when Rajavelu Esther sold 23,351 shares for $1.31 per share. The transaction valued at 30,590 led to the insider holds 396,515 shares of the business.
Rajavelu Esther sold 17,245 shares of SPRO for $22,418 on Nov 08 ’24. The CFO & CBO now owns 379,270 shares after completing the transaction at $1.30 per share. On Aug 27 ’24, another insider, Mahadevia Ankit, who serves as the Director of the company, sold 5,912 shares for $1.35 each. As a result, the insider received 7,981 and left with 759,085 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRO now has a Market Capitalization of 61605564 and an Enterprise Value of 5188984. As of this moment, Spero’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.23. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at 0.044 whereas that against EBITDA is 0.247.
Stock Price History:
Over the past 52 weeks, SPRO has reached a high of $1.89, while it has fallen to a 52-week low of $1.01. The 50-Day Moving Average of the stock is -10.43%, while the 200-Day Moving Average is calculated to be -20.64%.
Shares Statistics:
For the past three months, SPRO has traded an average of 240.33K shares per day and 327760 over the past ten days. A total of 53.00M shares are outstanding, with a floating share count of 39.37M. Insiders hold about 27.78% of the company’s shares, while institutions hold 19.35% stake in the company. Shares short for SPRO as of 1730332800 were 625191 with a Short Ratio of 2.28, compared to 1727654400 on 384302. Therefore, it implies a Short% of Shares Outstanding of 625191 and a Short% of Float of 1.4099999.
